Temozolomide for corticotroph pituitary adenomas refractory to standard therapy
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Temozolomide for corticotroph pituitary adenomas refractory to standard therapy
Authors
Keywords
-
Journal
Pituitary
Volume 14, Issue 1, Pages 80-91
Publisher
Springer Nature
Online
2010-10-23
DOI
10.1007/s11102-010-0264-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of Temozolomide in a patient with recurring oncocytic gonadotrophic pituitary adenoma
- (2014) Luis Syro et al. Hormones-International Journal of Endocrinology and Metabolism
- Radiation therapy and stereotactic radiosurgery for the treatment of Cushingʼs disease: an evidence-based review
- (2011) Robert M Starke et al. Current Opinion in Endocrinology Diabetes and Obesity
- Minimally Cytotoxic Doses of Temozolomide Produce Radiosensitization in Human Glioblastoma Cells Regardless of MGMT Expression
- (2010) M. S. Bobola et al. MOLECULAR CANCER THERAPEUTICS
- O-Methylguanine-DNA Methyltransferase Immunoexpression in a Double Pituitary Adenoma
- (2010) Safraz Mohammed et al. NEUROSURGERY
- Pasireotide Alone or with Cabergoline and Ketoconazole in Cushing's Disease
- (2010) Richard A. Feelders et al. NEW ENGLAND JOURNAL OF MEDICINE
- Carcinomes et adénomes hypophysaires agressifs : mise au point et nouvelles options thérapeutiques
- (2009) J.-C. Maïza et al. ANNALES D ENDOCRINOLOGIE
- O6-methylguanine DNA methyltransferase immunoexpression in nonfunctioning pituitary adenomas
- (2009) Georg Widhalm et al. CANCER
- High incidence of low O6-methylguanine DNA methyltransferase expression in invasive macroadenomas of Cushing's disease
- (2009) Akira Takeshita et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Temozolomide treatment of a pituitary carcinoma and two pituitary macroadenomas resistant to conventional therapy
- (2009) C Hagen et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Coexpression of Dopamine and Somatostatin Receptor Subtypes in Corticotroph Adenomas
- (2009) Christiaan de Bruin et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A novel use of temozolomide in a patient with malignant prolactinoma
- (2009) Stephen Byrne et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Phase II Trial of Temozolomide Plus O6-Benzylguanine in Adults With Recurrent, Temozolomide-Resistant Malignant Glioma
- (2009) Jennifer A. Quinn et al. JOURNAL OF CLINICAL ONCOLOGY
- An approach to the management of patients with residual Cushing’s disease
- (2009) Lewis S. Blevins et al. JOURNAL OF NEURO-ONCOLOGY
- USE OF TEMOZOLOMIDE IN AGGRESSIVE PITUITARY TUMORS
- (2009) Safraz Mohammed et al. NEUROSURGERY
- Low O6-methylguanine-DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumours
- (2008) Ann I. McCormack et al. CLINICAL ENDOCRINOLOGY
- Treatment of Nelson's syndrome with temozolomide
- (2008) V J Moyes et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Pituitary Carcinoma Presenting with Multiple Metastases: Case Report
- (2008) Aslan Guzel et al. JOURNAL OF CHILD NEUROLOGY
- Relevance of coexpression of somatostatin and dopamine D2 receptors in pituitary adenomas
- (2007) A. Saveanu et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now